• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Corneal implants numbers up again

Article

Des Plaines, IL?Addition Technology announces its fourth-quarter 2005 sales of Intacs corneal implants increased 29% over the same quarter the prior year and 12% over third-quarter 2005.

Des Plaines, IL-Addition Technology announces its fourth-quarter 2005 sales of Intacs corneal implants increased 29% over the same quarter the prior year and 12% over third-quarter 2005.

The corneal implants, which delay or eliminate the need for corneal transplant, are helpful for patients with keratoconus. They are also designed as an alternative to refractive surgery for patients with mild myopia. They are approved for use in the United States, Europe, Asia, Mexico, and parts of Latin America.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.